SMTL ID : 8fy2.1

E3:PROTAC:target ternary complex structure (VCB/WH244/BCL-2)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.98 Å
Oligo State
hetero-1-1-1-1-mer
Ligands
1 x YFH: N-({4-[2-(4-{[(4R)-4'-chloro-4-methyl-6-{[4-(4-{[4-{[(2R)-4-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]-1-(phenylsulfanyl)butan-2-yl]amino}-3-(trifluoromethanesulfonyl)benzene-1-sulfonyl]carbamoyl}phenyl)piperazin-1-yl]methyl}-2,3,4,5-tetrahydro[1,1'-biphenyl]-4-yl]methyl}piperazin-1-yl)-2-oxoethyl]piperazin-1-yl}acetyl)-3-methyl-L-valyl-(4S)-4-hydroxy-N-{(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl}-L-prolinamide(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Nayak, D. et al., Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL. Nat Commun (2024)
Release Date
2024-04-10
Peptides
von Hippel-Lindau disease tumor suppressor: A
Elongin-B: B
Elongin-C: C
Apoptosis regulator Bcl-2: D
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C
D
D